3DPOD Episode 49: Bioprinting with CELLINK Founder Dr. Hector Martinez

IMTS

Share this Article

On this episode of the 3DPOD, we go into bioprinting. With us is Hector Martinez, the CTO and a co-founder of CELLINK (CLNK-B.ST). CELLINK is a bioprinting rocket ship which took off only a few years ago. A small passionate team began selling bioinks and have since grown the company into a leader in bioprinting.

CELLINK is publicly traded and has a wide array of printers from the affordable to complex machines and from extrusion to DLP and holographic machines, as well. Martinez tells us about the foundation of CELLINK and the initial teams. He also has sage advice about how to know when your co-founders are the right partners for you. He talks to us as well about the near-term opportunities in bioprinting, what he expects from the market and where he expects interesting things to happen. If you are looking to explore bioprinting or are in the industry, this is a must-listen. I’d also recommend it to entrepreneurs and people with entrepreneurial spirits. You’ll walk away jazzed and informed from this one.

Share this Article


Recent News

3D Printing News Briefs, April 27, 2024: Research, Digital Dentistry, Cycling, & More

3D Printing News Unpeeled: Asahi Kasei Enters 3D Printing



Categories

3D Design

3D Printed Art

3D Printed Food

3D Printed Guns


You May Also Like

Further Understanding of 3D Printing Design at ADDITIV Design World

ADDITIV is back once again! This time, the virtual platform for additive manufacturing will be holding the first-ever edition of ADDITIV Design World on May 23rd from 9:00 AM –...

3D Printer Maker EVO-tech Reborn as NEVO3D — Once More With Feeling

EVO-tech was a 3D printing service and original equipment manufacturer established in 2013 and based in Schörfling am Attersee, Austria. The company produced high-quality material extrusion systems featuring linear bearings,...

3D Systems Brings 3D Printed PEEK Cranial Implant to the U.S. with FDA Clearance

For more than 10 years, 3D Systems (NYSE:DDD) has worked hand-in-hand with surgeons to plan over 150,000 patient-specific cases, and develop more than two million instruments and implants from its...

Sponsored

CDFAM Returns to Berlin for Second Annual Symposium

The second CDFAM Computational Design Symposium is scheduled for May 7-8, 2024, in Berlin, and will convene leading experts in computational design across all scales. Building upon the first event...